Safety Alert for Baxter and Althin dialalizers: (1) a-11, (2) a-15, (3) a-18, (4) a-22, (5) af-150, (6) All batches with the following product codes: (1) unidentified, (2) 237015, (3) 237018, (4) 237022, (5) 238015, (8) ax1500, (9) ax2200, (6) 238018, (7) 238022, (8 and 9) 239015, 239022, 239522

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Baxter International Inc.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    386
  • Date
    2001-11-16
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    UNTIL THIS DATE DOES NOT CONSERT PRODUCT REGISTRATION IN BRAZIL
  • Reason
    Baxter international has announced the discovery of a probable cause for the deaths of the 53 patients who occurred during the past month in establishments that use the above dialyzers. after extensive research, baxter discovered that the problem occurred in dialyzers containing perfluorohydrocarbon, a fluid used in the manufacture of about 10% of dialyzers manufactured at baxter's ronneby facility in sweden. perfluorohydrocarbon is a liquid at room temperature but turns into gas if it is warmed to body temperature, meaning that gas bubbles may have entered the bloodstream during hemodialysis, resulting in death of patients. perfluorohydrocarbon is not used in the manufacturing process for other dialyzers that baxter manufactures or distributes. baxter international has announced that it will permanently discontinue this way of manufacturing dialyzers as a precautionary measure. baxter, the fda and international regulatory agencies are continuing investigations to see if chemical fluid has been used by other filter manufacturers and whether other patients may have been affected. baxter international inc [305486], one baxter pkwy, deerfield il 60015.
  • Action
    After numerous investigations, Baxter identifies probable cause of recent deaths from hemodialysis patients [online news]. 5 November 2001 [quoted on November 8, 2001]. Available on the Internet: http://www.baxter.com/utilities/news/releases/2001/11-05dialyzer.html; U.S. Food and Drug Administration. FDA investigating the role of Baxter dialyzers in the deaths of patients on dialysis [online]. 7 November 2001 [quoted on November 8, 2001]. Available online: http://www.fda.gov/cdrh/recalls/dialyzers110701.html; Peterson M, Daly E. Baxter finds possible link between the 53 deaths [online]. NY Times November 6, 2001 [quoted on November 6, 2001]. Available on the Internet: http://www.nytimes.com Check for the receipt of the correction letter and response form dated October 18, 2001 from Baxter. Identify and isolate all affected products from your inventory. Baxter recommends that you suspend the use of all of the above products. Complete and return the answer form by fax 1 (847) 270-5457. If you have distributed these dialyzers to others, please send the correction letter and the response form to them immediately. For more information, please contact your local representative. Notify any occurrences associated with these products, to ANVISA, Technovigilance Unit, filling out the Health Product Associated Notifications Form available on the Internet http://www.anvisa.gov.br/tecnovigilancia and send directly online or save the file completed and send by e-mail tecnovigilância@anvisa.gov.br, or print it and send by fax 0xx61-4481257

Manufacturer

  • Source
    ANVSANVISA